Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.44
Delayed Data
As of Apr 29
 +0.18 / +3.42%
Today’s Change
2.80
Today|||52-Week Range
11.40
+7.72%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Tarnok Michael P
Director
Buy5/06/201510,000$9.73$97.3K-47.19%
Oliviero James F Iii
Chief Financial Officer
Buy5/12/201523,278$2.78$64.7K-48.88%
Neylan John F /keryx/
Chief Medical Officer
Buy8/12/201510,000$6.20$62.0K-18.58%
Madison Gregory P
President & Chief Executive Officer
Buy8/20/20159,984$5.69$56.8K-5.05%
Oliviero James F Iii
Chief Financial Officer
Buy5/12/201518,333$2.53$46.4K-48.88%
Holmes Scott A
Chief Financial Officer
Buy8/21/20155,000$5.72$28.6K-8.52%
Holmes Scott A
Chief Financial Officer
Sale7/31/20152,758$7.87$21.7K-34.09%
Madison Gregory P
President & Chief Executive Officer
Sale1/06/20164,261$4.83$20.6K+19.00%
Holmes Scott A
Chief Financial Officer
Buy11/03/20153,672$5.30$19.5K-2.59%
Oliviero James F Iii
Chief Financial Officer
Sale7/06/20151,943$9.61$18.7K-45.66%
Page of 4